{"issuance_frequency":"","notes_translated":{"fr":"Le zona est une infection virale aiguë causée par la réactivation du virus varicelle-zona (VVZ). Le VVVCZ, un vaccin à virus vivant (atténué) contre le zona, est offert au Canada depuis de nombreuses années. Un nouveau vaccin recombinant (sous-unitaire) contre le zona (VRZ) nommé Shingrix a été approuvé au Canada en octobre 2017. La présente revue de l’immunogénicité des vaccins contre le zona a pour but d’acquérir une compréhension approfondie de l’immunogénicité des vaccins à virus vivant et des vaccins sous-unitaires.","en":"Herpes zoster is an acute viral infection caused by reactivation of varicella-zoster virus (VZV). LZV, a live, attenuated vaccine for zoster has been available in Canada for many years. A new subunit recombinant zoster vaccine (RZV) named Shingrix was approved in Canada in October 2017. This zoster vaccine immunogenicity review was done to have a comprehensive understanding of the immunogenicity of both live and subunit vaccines."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"6199458f-e49d-4382-a9ad-6cad1d46b8b4","metadata_created":"2019-04-25T20:11:52.444548","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-04-25T20:11:52.444558","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-04-25","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Zona","infection","virale","aiguë","réactivation","virus varicelle-zona","VVZ","VVVCZ","vaccin","virus","vivant","atténué","offert","Canada","nombreuses","nouveau vaccin","recombinant","sous-unitaire","VRZ","Shingrix","Canada","2017","immunogénicité"],"en":["Herpes","zoster","acute","viral","infection","reactivation","varicella-zoster virus","VZV","LZV","live","attenuated","vaccine","zoster","Canada","subunit","recombinant zoster vaccine","RZV","Shingrix","Canada","2017","zoster vaccine","immunogenicity","live","subunit vaccines"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Revue de la littérature sur l’immunogénicité des vaccins contre le zona","en":"Literature Review on the Immunogenicity of Herpes Zoster Vaccines"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"6199458f-e49d-4382-a9ad-6cad1d46b8b4","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8adc2e2e-de3f-4b07-a331-186b766b5fe3","related_relationship":"","name_translated":{"fr":"Revue de la littérature sur l’immunogénicité des vaccins contre le zona","en":"Literature Review on the Immunogenicity of Herpes Zoster Vaccines"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Literature Review on the Immunogenicity of Herpes Zoster Vaccines","language":["en"],"created":"2019-04-25T20:11:53.120265","url":"https://www.canada.ca/en/public-health/services/publications/healthy-living/literature-review-immunogenicity-herpes-zoster-vaccines.html","last_modified":null,"position":0,"revision_id":"8e5d3005-f653-4d2f-bacc-41476902062c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6199458f-e49d-4382-a9ad-6cad1d46b8b4","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d685e93d-7151-4e18-9959-03cf016f7f67","related_relationship":"","name_translated":{"fr":"Revue de la littérature sur l’immunogénicité des vaccins contre le zona","en":"Literature Review on the Immunogenicity of Herpes Zoster Vaccines"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Literature Review on the Immunogenicity of Herpes Zoster Vaccines","language":["fr"],"created":"2019-04-25T20:11:53.120275","url":"https://www.canada.ca/fr/sante-publique/services/publications/vie-saine/revue-litterature-immunogenicite-vaccins-contre-zona.html","last_modified":null,"position":1,"revision_id":"8e5d3005-f653-4d2f-bacc-41476902062c","resource_type":"website"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2019-02-11 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"6199458f-e49d-4382-a9ad-6cad1d46b8b4","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Herpes zoster is an acute viral infection caused by reactivation of varicella-zoster virus (VZV). LZV, a live, attenuated vaccine for zoster has been available in Canada for many years. A new subunit recombinant zoster vaccine (RZV) named Shingrix was approved in Canada in October 2017. This zoster vaccine immunogenicity review was done to have a comprehensive understanding of the immunogenicity of both live and subunit vaccines.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Literature Review on the Immunogenicity of Herpes Zoster Vaccines","revision_id":"8e5d3005-f653-4d2f-bacc-41476902062c"}